134 related articles for article (PubMed ID: 19099199)
21. Temozolomide as second-line chemotherapy for relapsed gliomas.
Trent S; Kong A; Short SC; Traish D; Ashley S; Dowe A; Hines F; Brada M
J Neurooncol; 2002 May; 57(3):247-51. PubMed ID: 12125988
[TBL] [Abstract][Full Text] [Related]
22. [Favourable result for temozolomide in recurrent high-grade glioma].
Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
[TBL] [Abstract][Full Text] [Related]
24. Temozolomide for recurrent low-grade spinal cord gliomas in adults.
Chamberlain MC
Cancer; 2008 Sep; 113(5):1019-24. PubMed ID: 18615600
[TBL] [Abstract][Full Text] [Related]
25. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
Kyritsis AP; Levin VA
Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
[TBL] [Abstract][Full Text] [Related]
26. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
[TBL] [Abstract][Full Text] [Related]
27. Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report.
Dufour C; Da Costa L; Auger N; Jullien M; Bhangoo R; Grill J
J Pediatr Hematol Oncol; 2008 Nov; 30(11):857-9. PubMed ID: 18989164
[TBL] [Abstract][Full Text] [Related]
28. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
29. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
van den Bent MJ
Semin Oncol; 2003 Dec; 30(6 Suppl 19):39-44. PubMed ID: 14765384
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
32. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
[TBL] [Abstract][Full Text] [Related]
33. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas.
Sherman JH; Moldovan K; Yeoh HK; Starke RM; Pouratian N; Shaffrey ME; Schiff D
J Neurosurg; 2011 Jun; 114(6):1617-21. PubMed ID: 21235313
[TBL] [Abstract][Full Text] [Related]
34. Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit.
Gupta T; Mohanty S; Moiyadi A; Jalali R
Clin Neurol Neurosurg; 2013 Sep; 115(9):1814-9. PubMed ID: 23764039
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
36. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
Chamberlain MC
Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
[TBL] [Abstract][Full Text] [Related]
37. Neuro-oncology: the growing role of chemotherapy in glioma.
Carpentier AF
Lancet Neurol; 2005 Jan; 4(1):4-5. PubMed ID: 15620846
[No Abstract] [Full Text] [Related]
38. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
[TBL] [Abstract][Full Text] [Related]
39. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
40. A Case of Therapy-Related Acute Myeloid Leukemia Associated with Adjuvant Temozolomide Chemotherapy for Anaplastic Astrocytoma.
Kosugi K; Saito K; Takahashi W; Tokuda Y; Tomita H
World Neurosurg; 2017 May; 101():816.e11-816.e16. PubMed ID: 28288919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
